ERI3
ERI1 exoribonuclease 3
Also known as: ERI3_HUMAN, FLJ22943, PINT1, PRNPIP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43414
- Gene
- ERI3
- Ensembl
- ENSG00000117419
- Chromosome
- 1
- Canonical length
- 337 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables RNA binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
337 residues, UniProt reviewed canonical sequence.
>O43414|ERI3
1 MATASPAADG GRGRPWEGGL VSWPPAPPLT LPWTWMGPSW GQHPGHWGFP ALTEPSASPA
61 AGLGIFEVRR VLDASGCSML APLQTGAARF SSYLLSRARK VLGSHLFSPC GVPEFCSIST
121 RKLAAHGFGA SMAAMVSFPP QRYHYFLVLD FEATCDKPQI HPQEIIEFPI LKLNGRTMEI
181 ESTFHMYVQP VVHPQLTPFC TELTGIIQAM VDGQPSLQQV LERVDEWMAK EGLLDPNVKS
241 IFVTCGDWDL KVMLPGQCQY LGLPVADYFK QWINLKKAYS FAMGCWPKNG LLDMNKGLSL
301 QHIGRPHSGI DDCKNIANIM KTLAYRGFIF KQTSKPFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ERI3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 100 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 100 nTPM
- amygdala: 93 nTPM
- hippocampal formation: 91 nTPM
- basal ganglia: 90 nTPM
- testis: 85 nTPM
- choroid plexus: 79 nTPM
Single-cell type
- late spermatids: 1,634 nCPM
- early spermatids: 241 nCPM
- choroid plexus epithelial cells: 234 nCPM
- proximal tubule cells: 166 nCPM
- lactotrophs: 148 nCPM
- astrocytes: 145 nCPM
Immune cell
- myeloid DC: 40 nTPM
- non-classical monocyte: 38 nTPM
- intermediate monocyte: 36 nTPM
- naive B-cell: 31 nTPM
- memory B-cell: 31 nTPM
- plasmacytoid DC: 30 nTPM
Brain region
- pons: 139 nTPM
- cerebral cortex: 113 nTPM
- hippocampal formation: 112 nTPM
- midbrain: 110 nTPM
- thalamus: 104 nTPM
- amygdala: 101 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.2
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ERI3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ERI3 as an antibody target. Whether an autoantibody or antibody against ERI3 could matter depends on whether native ERI3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ERI3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ERI3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...